are healthcare workers who are on the front lines,  

as well as anybody who works in a hospital, and  then those who live in skilled nursing facilities.  

Skilled nursing facilities account for about 6%  of the population, but almost 40% of the deaths  

due to COVID. So these are very high-risk  individuals for bad outcomes from COVID.  

It looks like it's the same kind of side effects  that you would get from influenza or a tetanus  

shot. You get a sore arm for a day or two,  maybe a headache or fatigue, and then that  

goes away.

There's no way that you can get  COVID from the coronavirus vaccine.

There's absolutely no way. It's just a small fragment  of the RNA that encodes

for a small portion of the spike protein.

So it doesn't replicate, it can't replicate, and it can't cause COVID.

We're going to have to be masking and social  distancing for the foreseeable future. When we'll  

be able to stop masking and social distancing is  when we achieve some level of herd immunity within  

our communities. That's going to take 60 to 70%  of the population to be immune. Right now, through  

infection, if people are immune after infection,  which we're still not sure, there's been less than  

10% of people in the US who have been infected.  And then when the vaccine comes out, it's going to  

come out in limited quantities, and so we're not going  to be able to vaccinate everybody all at once.  

So, we anticipate that we will be able to achieve  that 60 to 70% immunity either through infection  

plus immunization in maybe the middle of 2021,  maybe the end of 2021. We'll just have to see.  

There's three main vaccines, and two  of them are messenger RNA vaccines,  

mRNA, and those are the ones produced by Pfizer  as well as Moderna. Those vaccines, what they are,  

is a fragment of the messenger RNA that encodes  for a certain portion of the spike protein of  

the coronavirus. That's the vaccine. So when  that is given to us, then our own cells make  

that protein, just a fragment of that protein, and  then we have an immune response to that protein.  

That's how they work to develop  immunity. The other vaccine is  

similar. The Oxford AstraZeneca vaccine,  it's a non replicating adenovirus vector  

that again has a fragment of the spike protein,  and so then we get an immune response to that.